chrisvoncsefalvay/vaers-outcomes huggingface dataset:
somewhat of a rash; 100 F temperature; extreme fatigue; pain at arthritis point; This spontaneous case was reported by a patient and describes the occurrence of RASH (somewhat of a rash), PYREXIA (100 F temperature), FATIGUE (extreme fatigue) and ARTHRALGIA (pain at arthritis point) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included DIAZEPAM (VALIUM) for Anxiety, DULOXETINE HYDROCHLORIDE (CYMBALTA) for Fibromyalgia, ASCORBIC ACID (VITAMIIN C), VITAMIN D NOS, CALCIUM and ZINC for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (somewhat of a rash), PYREXIA (100 F temperature), FATIGUE (extreme fatigue) and ARTHRALGIA (pain at arthritis point). The patient was treated with PARACETAMOL (TYLENOL) for Rash, at an unspecified dose and frequency. At the time of the report, RASH (somewhat of a rash), PYREXIA (100 F temperature), FATIGUE (extreme fatigue) and ARTHRALGIA (pain at arthritis point) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) 100 F temperature.         Patient reports that she has a genetic defect called MThfr compound heterozygous. It means sometimes she methylates, or absorb medications very quickly, and there are other times where she absorbs medications very slowly. They are not quite sure what will happen in either situation. Concomitant includes Thyroid medication.      This case was linked to MOD-2021-329852, MOD-2021-329883 (Patient Link).
Patient was vaccinated with an expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old male patient who received DTPa-IPV (Kinrix) (batch number 3DZ45, expiry date 15th January 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 7th March 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 7th March 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The patient was vaccinated with an expired dose of Kinrix, which led to expired vaccine used.  The reporter consented to follow up.
Immediately after receiving the vaccine the patient reported itching over her right breast. The pharmacist visualized a 3inch in diameter erythema on the right breast. The patient denied changes in breathing or any difficulty in breathing. Benadryl 25mg po was given.  27 minutes after the Benadryl was given the patients breathing was louder and the itching had spread over her chest, back, and throat. The patient was clearing her throat with coughing. The patient then reported to the ER.
My arm felt a bit swollen on day 10.  By day 11 I have a reddened area around the site.  I took 50mg of Benadryl.
No adverse effects reported; a female 1 year old received properly stored PROQUAD and properly stored VARIVAX on the same day; Information has been received from a medical assistant referring to a 1 year old female patient. Information about concurrent condition, concomitant medication and medical history was not provided.    On 09-JUL-2019, the patient received properly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot# S002501, expiration date 23-JUL-2020, in the right thigh; strength, dose and route were unknown) and properly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) (expiration date 23-JAN-2021, in the left thigh; strength, dose, route and lot # were unknown) for prophylaxis on the same day (overdose). Both measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and varicella virus vaccine live (Oka/Merck) (VARIVAX) were reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT) (lot# R012275, expiration 28-JAN-2021; the same lot was used for both vaccines). No adverse effects was reported.
Sudden low back pain; stiffness; difficult to get comfortable; very difficult to stand up or move around; very difficult to stand up or move around; bedridden; This is a spontaneous report from a contactable consumer. A 67-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9266, Expiration date: Unknown) on 09Feb2021 at 24:00 via an unspecified route of administration in the right arm at SINGLE DOSE for COVID-19 Immunization in the hospital. The patient's medical condition included Breast cancer from 2020, NDPH (New daily persistent headache) since 1973 and Food intolerances not anaphylactic reactions: Gluten, peppermint from an unknown date and unknown from ongoing. The patient's concomitant medications were not reported. The patient previously had first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9261, Expiration date: Unknown) on 19Jan2021 at 11:30 via an unspecified route of administration in the right arm at SINGLE DOSE for COVID-19 Immunization. The patient had not used any other vaccine in four weeks and not in two weeks. On 10Feb2021 18:00 the patient had sudden low back pain and stiffness beginning about 36 hours following 2nd vaccination. (The first 36 hours, I felt great-seemed to have extra energy. No injection site pain.) Pain and stiffness made it difficult to get comfortable, and it was very difficult to stand up or move around. I was bedridden for about 24 hours. Today is day 5 after vaccination, and I still have some pain/stiffness albeit much less severe. The patient had not tested for COVID-19 prior to vaccination and post vaccination. The patient did not receive treatment medication. The outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected.
This case was reported by a consumer (the subject) and described the occurrence of latex allergic reaction in a female subject of unspecified age who was vaccinated with Influenza vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. On an unspecified date the subject received a dose of Influenza vaccine (details unknown). At an unspecified time after vaccination with Influenza vaccine, the subject experienced latex allergic reaction. The consumer reported that she once got a flu shot and had a reaction to the latex content. At the time of reporting the outcome of the event was unspecified. No further information was provided.
I had a skin reaction after both the first and second injection; This case was reported by a consumer and described the occurrence of skin reaction in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced skin reaction. On an unknown date, the outcome of the skin reaction was unknown.   It was unknown if the reporter considered the skin reaction to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The patient had skin reaction after 1st dose. For tolerance to 2nd dose, refer case US2020AMR065889.
On July 2nd I presented at the urgent care center thinking that I had a sinus infection. I was given two COVID tests--a rapid antigen and PCR. The antigen test was positive. The PCR later came back negative. I was also given antibiotics for the sinus infection. The illness cleared up upon completion of the full course of antibiotics.
Indigestion like symptoms; Started my period 2 days later; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Aug2021 (Batch/Lot number: unknown) at the age of 32 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: TYLENOL. The following information was reported: MENSTRUATION DELAYED (non-serious) with onset 2021, outcome "unknown", described as "Started my period 2 days later"; DYSPEPSIA (non-serious) with onset 23Aug2021, outcome "unknown", described as "Indigestion like symptoms". Therapeutic measures were not taken as a result of menstruation delayed, dyspepsia.  Additional information: It was reported that the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that after first Pfizer dose 23Aug2021 that day she experienced indigestion like symptoms but didn't think anything of it and started her period 2 days later. My second dose was 13Sep2021 and that day she experienced intense stomach cramps so bad they woke up through the night, that lasted 2 days, had diarrhea, then had period cramps which normally don't have due to birth control and started period again. Which is obviously early given the 3 week period between vaccines. No Treatment was not Received. The patient was not diagnosed with covid-19, prior to vaccination. The patient has not been tested for covid-19, since the vaccination. Follow-up attempts completed. No further information is expected.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Mother noted left anterior thigh with 10 cm or so area of mild/soft edema, with mild bluish central contusion.
I woke up panting, with a very fast heartbeat, and very dizzy, all day long. It came back for many days.
Pt vaccinated with DTP/OPV developed temp 100.6, fussy at 4am, vomited formula, temp 104.6 was seen in office doing better.
had COVID (double Covid pneumonia); A spontaneous report (United States) was received from an Other Health Care Professional concerning a female patient age not provided who developed COVID (double Covid pneumonia)   The patient's medical history was not provided. Concomitant product use was not provided.  On 22-Jan-2021, prior to the onset of events, the patient had the first of two planned doses of mRNA-1273, (Batch number was not provided) (route and site was not provided) for prophylaxis of Covid-19 infection.  The patient left a voicemail message reporting adverse reactions to the Moderna mRNA-1273 vaccine. The patient reported having "Covid".  She reported being hospitalized with, " double Covid pneumonia". No treatment information or hospitalization details were provided.  Agent called the patient back on 26-Jan-2021 and was unable to reach her for more information.  Action taken with mRNA-2021 in response to the events was not reported.  Outcome of the event had COVID (double Covid pneumonia) was unknown.; Reporter's Comments: This case concerns a female of unknown age who was hospitalized with a serious unexpected event of COVID-19 pneumonia.  The event occurred with unknown latency after the first dose of mRNA-1273. Treatment not reported. Event outcome unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
did not have any allergy until I had 1st dose of Pfizer. In 1 or 2 weeks after 1st dose, heavily experience eye allergy (itching and redness, not swelling). The cause could be possibly by debris of grass and flower pollen.
Mother returned with child on 3/20/14 - (L) upper arm red, warm to touch and swollen, blisters noted just above elbow - swelling noted from deltoid to elbow and around arm. Mother took child to urgent care - states she was told it was a local reaction and to use cool, wet compress.
pt came to clinic in w/c 1155am c/o dizziness, SOB, SpO2 RA 96%, BP176/98 P76 1200 drinking water 1206 BP 147/80 P67 - better 1208 pt and husband, walked with staff (RN) to car
Medication error without adverse drug reaction. No harm to the patient. He should have received the full 0.5mL dose of Moderna not the booster dose of 0.25mL.
TENDERNESS AT SITE; REDNESS AT SITE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced tenderness at site, and redness at site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the tenderness at site and redness at site was not reported. This report was non-serious.
Rash/Hives starting the evening of the vaccine. The next morning severe brain fog to the point of not being able to complete any daily task, uncontrollable emotional and mental melt down, severe headache, feeling of being highly medicated, nausea, and stomach cramps. All of the sever symptoms lasted for 3 days after the vaccine. It has been 13 days now and the brain fog is still present, unable to focus on work tasks, and daily headache are still present.
Evening of injection (10/27/16) swelling, redness, hard core developed at site. By Friday, noon, pain was worse, I could not lift significant weight (over 10lb). Friday evening thru Sunday morning (10/28-10/30) I had chills and fever. Symptoms looked similar to cellulitis extended from shoulder to elbow.
My blood pressure started going up very high & then my blood pressure kept going up, so I went to doctor & now I am on high blood pressure 7 also I was referred to a cardiologist.
Multiple vaccines given in error. Total of 3 children in room at time of injections. LPN present to assist  RN with injections. Patient was due for only Hepatitis A today and she did receive that injection but also received Four others that she was not due for this date of 5/3/2018. FNP made aware of error on 5/4/2018. Patient Guardian contacted (Grandmother) and notified, made of aware of incident. Negative injury to patient. Grandmother denies any complaints from child, only some redness to right thigh where 2 injections were given.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     The patient's past medical history included Morbid obesity and Asthma. Concurrent medical conditions included Allergy to metals. Concomitant products included PRENATAL MULTIVITAMIN + DHA for Pregnancy.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 19-Jan-2021 and the estimated date of delivery was 26-Oct-2021. On 05-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  tenth week of the pregnancy.  On 05-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Pregnancy test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported Patient experienced pregnancy associated heartburn and fatigue. Patient has previous one pregnancy which was live birth and full term birth.
Rash and itching on her upper torso, it gets more intense and it's spreading to her parts of her body; Rash and itching on her upper torso, it gets more intense and it's spreading to her parts of her body; Also got the flu shot at the same time.; Also got the flu shot at the same time.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 77 year-old female patient received bnt162b2 (BNT162B2), administration date 01Oct2021 (Batch/Lot number: unknown) at the age of 77 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU), administration date 01Oct2021 (Batch/Lot number: unknown). Relevant medical history included: "severe degenerative joint disease" (unspecified if ongoing), notes: severe degenerative joint disease; "muscle aches" (ongoing), notes: 20 years ago and this is ongoing so when she gets any shot and they say muscle aches, joint pain, fatigue, headache; "fatigue" (ongoing), notes: 20 years ago and this is ongoing so when she gets any shot and they say muscle aches, joint pain, fatigue, headache; "headache" (ongoing), notes: 20 years ago and this is ongoing so when she gets any shot and they say muscle aches, joint pain, fatigue, headache; "joint pain" (ongoing), notes: 20 years ago and this is ongoing so when she gets any shot and they say muscle aches, joint pain, fatigue, headache. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose:02), administration date: 10Mar2021, when the patient was 77 years old, for COVID-19 immunization; Bnt162b2 (Dose:01), administration date: Feb2021, when the patient was 77 years old, for COVID-19 immunization. The following information was reported: RASH (non-serious), PRURITUS (non-serious) all with onset 09Oct2021, outcome "not recovered" and all described as "Rash and itching on her upper torso, it gets more intense and it's spreading to her parts of her body"; PRODUCT USE ISSUE (non-serious), OFF LABEL USE (non-serious) all with onset 01Oct2021, outcome "unknown" and all described as "Also got the flu shot at the same time.".  Additional information : Reporter seriousness of the events was reported as unspecified.Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 08-FEB-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017). This specified lot number vaccine was exposed to temperature excursion one time. The total cumulative excursion time of the first time was 104 hours with the highest recorded temperature of 53 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
I do not know if i put the right vaccine above ...on 10/31/2012 he had the fluzone 6mo>.   Event he actually had two appts following this vaccine. first- 12/6/12 I took him to quick care,  he was projectile vomiting they dx him as gastritis. second took him to emergency room, he had a fever of 106, they dx as pharyngitis and otitis media.
Mild fever, all over aches and pain, local stiffness. I never have adverse reactions other than local soreness, to shots including the anthrax series received while in military. This shot has made the last 12 hours miserable.
Manifested generalized myalgias, arthralgias, abdominal pain, fever after receiving Td immunization following puncture wound to ? suspect serum sickness secondary to Td injection. The discharge summary received on 2/18/04 states diarrhea, nausea, leg pain, tearfull, shaking, rigors, weak, and arthrus reaction.
patient received vaccination from outside source.  I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 6/23/2021 DO NOT RESUSCITATE STATUS J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 6/23/2021 DO NOT RESUSCITATE STATUS
nausea; chills; headache; joint pain; fatigue; A spontaneous report was received from a consumer concerning a 69-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events chills, headache, joint pain, nausea, fatigue.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 21 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 029L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 21 Jan 2021, the patient experienced fatigue. \On 25 Jan 2021, the patient experienced chills, headache and joint pain. On 26 Jan 2021, the patient experienced nausea.  Treatment details was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event nausea was considered resolved on 26 Jan 2021.The outcome of events- joint pain and chills-was considered to be resolved on 27 Jan 2021. Headache was considered to be resolved on 28 Jan 2021.The outcome of event-fatigue was considered to be resolved on 29 Jan 2021.
This case was reported by a consumer and described the occurrence of decreased therapeutic response in a female subject aged between 40 and 49 years old  who was vaccinated with HEPATITIS B vaccine (manufacturer not reported). A physician or other health care professional has not verified this report.  On an unspecified date approximately twenty years ago, the subject received unspecified dose of HEPATITIS B vaccine (unknown). On 29 March 2009, approximately 20 years after vaccination with HEPATITIS B vaccine, the subject experienced decreased therapeutic response. The reporter indicated that the subject's titer was 0.40 and the subject was vaccinated approximately 20 years ago with an unknown manufacturer's hepatitis vaccine. The reporter also indicated that another subject, who also received an unknown manufacturer's hepatitis B vaccine ten years ago, experienced a titer level of 0.60 (see case for more details on this subject).
pt reports was at home & had a sudden onset of SOB;pt then went to local ER;BP grossly elevated 230/150;treated for pulmonary edema & released 19SEP97;
Patient became dizzy and jittery about 30 minutes after shot, when she got home went to sleep. When she woke up her left side numb. She also experience some shortness of breath and had body aches, fever, chills for 3 days.